ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 146 filers reported holding ITEOS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,869,500 | +14.5% | 810,000 | +38.5% | 0.69% | +24.1% |
| Q2 2023 | $7,745,400 | +18.6% | 585,000 | +21.9% | 0.56% | +14.2% |
| Q1 2023 | $6,532,800 | +123.0% | 480,000 | +220.0% | 0.49% | +96.4% |
| Q4 2022 | $2,929,500 | -45.9% | 150,000 | -25.2% | 0.25% | +17.5% |
| Q3 2021 | $5,410,000 | – | 200,413 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $29,989,696 | 16.06% |
| MPM BioImpact LLC | 1,745,943 | $19,118,076 | 5.10% |
| Saturn V Capital Management LP | 994,756 | $10,892,578 | 4.56% |
| Boxer Capital, LLC | 1,804,058 | $19,754,435 | 1.05% |
| RA Capital Management | 4,417,259 | $48,368,986 | 0.95% |
| 683 Capital Management, LLC | 810,000 | $8,869,500 | 0.69% |
| Ikarian Capital, LLC | 346,471 | $3,793,857 | 0.46% |
| Ikarian Capital, LLC | 3,056 | $3,346,320 | 0.40% |
| BVF INC/IL | 1,259,476 | $13,791,262 | 0.37% |
| DAFNA Capital Management LLC | 98,560 | $1,079,232 | 0.34% |